Kidney-tonifying and blood-activating in treatment of infertility due to pelvic inflammatory disease:clinical experience of Professor MA Kun.
10.19540/j.cnki.cjcmm.20210224.502
- Author:
Kun MA
1
;
Min LI
1
Author Information
1. China Academy of Chinese Medical Sciences Beijing 100700, China.
- Publication Type:Journal Article
- Keywords:
infertility;
kidney deficiency and blood stasis;
kidney-tonifying and blood-activating;
pelvic inflammatory disease(PID)
- MeSH:
Female;
Humans;
Infertility, Female/etiology*;
Kidney;
Medicine, Chinese Traditional;
Pelvic Inflammatory Disease/drug therapy*;
Pregnancy;
Pregnancy Rate
- From:
China Journal of Chinese Materia Medica
2021;46(11):2639-2643
- CountryChina
- Language:Chinese
-
Abstract:
Pelvic inflammatory disease(PID) has become one of the leading causes of female infertility, with an increasing incidence in recent years. Modern medicine believes that risk factors of PID will affect the formation of eggs and embryo implantation, especially on the encounter of gametes, fertilization, and transport of fertilized eggs to the uterine cavity. Therapies for infertility due to PID include medication, sonographic hydrotubation, surgery, and assisted reproductive technology. Professor Ma Kun believes that the disease is located in the uterus with appendages with the main pathogenesis of kidney deficiency and blood stasis. Blood stasis is the pathological basis, and kidney deficiency is the fundamental pathogenesis, which exhibits deficiency-excess in complexity. Kidney deficiency will cause blood stasis over time, while blood stasis will aggravate kidney deficiency in turn, making PID-induced infertility refractory. In clinical practice, basic therapies follow the principles of kidney-tonifying and blood-activating, removing blood stasis, dredging collaterals, and coordinating thoroughfare and conception vessels. The oral administration of Chinese medicine combined with enema, external application, and external washing displays better efficacy in improving the pelvic microenvironment and increasing the pregnancy rate and pregnancy success rate in the treatment of PID-induced infertility.
